These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Public-private partnerships and global health equity: prospects and challlenges. Asante AD; Zwi AB Indian J Med Ethics; 2007; 4(4):176-80. PubMed ID: 18630239 [TBL] [Abstract][Full Text] [Related]
24. Initial lessons from public-private partnerships in drug and vaccine development. Wheeler C; Berkley S Bull World Health Organ; 2001; 79(8):728-34. PubMed ID: 11545329 [TBL] [Abstract][Full Text] [Related]
25. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation. Patel AC; Coyle AJ Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247 [No Abstract] [Full Text] [Related]
26. Implementing a public-private mix model for tuberculosis treatment in urban Pakistan: lessons and experiences. Naqvi SA; Naseer M; Kazi A; Pethani A; Naeem I; Zainab S; Fatmi Z Int J Tuberc Lung Dis; 2012 Jun; 16(6):817-21. PubMed ID: 22507031 [TBL] [Abstract][Full Text] [Related]
27. Indian biotechnology--rapidly evolving and industry led. Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682 [No Abstract] [Full Text] [Related]
28. The innovative medicines initiative: a European response to the innovation challenge. Goldman M Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619 [TBL] [Abstract][Full Text] [Related]
30. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry. Zhang Z; Jia M; Wan D Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467 [TBL] [Abstract][Full Text] [Related]
31. Healthcare identities at the crossroads of service modernisation: the transfer of NHS clinicians to the independent sector? Waring J; Bishop S Sociol Health Illn; 2011 Jul; 33(5):661-76. PubMed ID: 21314688 [TBL] [Abstract][Full Text] [Related]
32. Public-private collaboration in health and human service delivery: evidence from community partnerships. Bazzoli GJ; Stein R; Alexander JA; Conrad DA; Sofaer S; Shortell SM Milbank Q; 1997; 75(4):533-61. PubMed ID: 9415091 [TBL] [Abstract][Full Text] [Related]
34. South Korean biotechnology--a rising industrial and scientific powerhouse. Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684 [No Abstract] [Full Text] [Related]
35. Efficiency and productivity changes in large urban hospitals 1994-2002: ownership, markets, and the uninsured. Ferrier GD; Valdmanis VG Adv Health Econ Health Serv Res; 2008; 18():157-76. PubMed ID: 19725361 [No Abstract] [Full Text] [Related]
36. The emergence of Egyptian biotechnology from generics. Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680 [No Abstract] [Full Text] [Related]
37. Pierre Meulien. Meulien P; Mullard A Nat Rev Drug Discov; 2015 Aug; 14(8):521. PubMed ID: 26228752 [No Abstract] [Full Text] [Related]
38. Global strategic partnerships in regenerative medicine. French A; Suh JY; Suh CY; Rubin L; Barker R; Bure K; Reeve B; Brindley DA Trends Biotechnol; 2014 Sep; 32(9):436-40. PubMed ID: 25150363 [TBL] [Abstract][Full Text] [Related]
39. Public-private partnerships. Going into labour. Lissauer R Health Serv J; 2001 Jun; 111(5761):24-5. PubMed ID: 11458560 [TBL] [Abstract][Full Text] [Related]